Lombard Odier Asset Management (USA)’s Axsome Therapeutics AXSM Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,379	Closed	-$289K	–	239
2025 Q3	$289K	Sell	2,379 -27	-1%	-$3.04K	0.02%	368
2025 Q2	$251K	Buy	+2,406	New	+$255K	0.02%	332
2017 Q1	–	Sell	-250,000	Closed	-$1.69M	–	209
2016 Q4	$1.69M	Sell	250,000 -78,061	-24%	-$548K	0.21%	114
2016 Q3	$2.58M	Sell	328,061 -13,729	-4%	-$104K	0.24%	122
2016 Q2	$2.58M	Buy	341,790 +9,400	+3%	+$86.6K	0.31%	88
2016 Q1	$2.86M	Sell	332,390 -8,702	-3%	-$79.9K	0.39%	94
2015 Q4	$3.11M	Buy	+341,092	New	+$3M	0.3%	103

Other funds holding AXSM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s AXSM Position: Q4 2025 in Review

Lombard Odier Asset Management (USA) sold out of Axsome Therapeutics (AXSM) in Q4 2025, closing a stake of 2,379 shares — an estimated $289K sold.

Lombard Odier Asset Management (USA) first reported a position in AXSM in Q4 2015 and held it in 7 quarters. The position peaked at $3.11M in Q4 2015. 400 funds tracked by Wall St. Rank hold AXSM as of Q4 2025.

Lombard Odier Asset Management (USA) reported no remaining Axsome Therapeutics position as of Q4 2025 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 2,379 Axsome Therapeutics shares in Q4 2025, an estimated $289K.
Lombard Odier Asset Management (USA) first reported a position in Axsome Therapeutics in Q4 2015 and held it in 7 quarters.
Lombard Odier Asset Management (USA)'s Axsome Therapeutics position peaked at $3.11M in Q4 2015.
400 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q4 2025.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q4 2025, filed 17 Feb 2026.